Adrenocortical Carcinoma

Search Trials
Study to Evaluate CORT125134 in Participants With Cushing's Syndrome
Status:
Completed
Last Changed:
Oct 15, 2019
First Changed:
Jun 17, 2016
Disease(s):
Cushing's Syndrome
Intervention(s):
CORT125134
Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors
Status:
Recruiting
Last Changed:
Jul 7, 2021
First Changed:
Nov 7, 2017
Disease(s):
Genitourinary Cancer
Intervention(s):
IpilimumabNivolumab
A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IPI-549
Status:
Active, not recruiting
Last Changed:
Apr 4, 2022
First Changed:
Dec 22, 2015
Disease(s):
Advanced Solid Tumors (Part A/B/C/D)
Intervention(s):
IPI-549 (eganelisib)Nivolumab
Combination Chemotherapy With Suramin Plus Doxorubicin in Treating Patients With Advanced Solid Tumors
Status:
Completed
Last Changed:
Aug 3, 2011
First Changed:
Apr 30, 2004
Disease(s):
Adrenocortical Carcinoma
Intervention(s):
doxorubicin hydrochloridesuramin
Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor
Status:
Active, not recruiting
Last Changed:
Mar 25, 2022
First Changed:
Mar 17, 2006
Disease(s):
Stage I Adrenocortical Carcinoma
Intervention(s):
doxorubicin hydrochlorideconventional surgerycisplatinmitotaneetoposidefilgrastim

Connect. Empower. Inspire.